Home > Lab Tests > Canassist - Breast (L) Test

Canassist - Breast (L) Test

₹ 75000

Home Collection Not Available

Test Name :	Canassist - Breast (L) Test
Sample Type :	Formalin fixed paraffin embedded tissue
Gender :	Both
Age group :	All Age Groups
Report Timeline :	15 Days
This Test Includes :	Canassist - Breast 1 Tests

Price :

₹ 75000

Canassist - Breast (L) Test Includes:
1 Tests Know More

Description
- Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassist breast test analyses tumour biology through protein expression. This procedure helps oncologists to decide whether chemotherapy is required or not. By distinguishing between low and high-risk patients, the Canassist breast test supports personalised treatment decisions, allowing many to avoid ....Read More

CANASSIST BREAST TEST SAMPLE REPORT

Track and manage your health better with SAMPLE REPORT

Recommended Tests

FAQs

About Canassist - Breast (L) Test

Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassi

When is the Test Prescribed?

Canassist breast cancer can develop due to a combination of genetic, hormonal, and lifestyle factors. The primary causes include age and gender, with women over the age of 40 being most commonly affected. A family history of breast cancer or known genetic mutations, such as BRCA1 and BRCA2, can significantly increase risk. Hormonal influences, particularly prolonged hormone replacement therapy, can also contribute. Additional factors like obesity, alcohol consumption, and environmental exposure are known to elevate the likelihood of developing Canassist breast cancer. Understanding these risks helps identify when a patient might benefit from the Canassist breast test.

Symptoms prompting consideration of the Canassist Breast lab test often include the presence of a new lump in the breast or underarm, noticeable changes in the shape, size, or appearance of the breast, or alterations in the nipple such as discharge, inversion, or unusual tenderness. Patients may also experience persistent breast pain or observe redness, dimpling, or irritation of the breast skin. While these signs do not always confirm cancer, they are indicators that warrant medical evaluation. If breast cancer is confirmed, the Canassist Breast test is a valuable next step to assess the likelihood of recurrence.

In terms of prevention, although not all types of Canassist Breast cancer can be entirely avoided, there are proactive steps individuals can take to lower their risk. These include attending regular screenings and mammograms, adopting a healthy diet, maintaining a proper weight, engaging in physical activity, and moderating alcohol consumption. It is also advisable to avoid tobacco use and carefully manage any hormone-based therapies.

The Canassist breast test is generally prescribed after the surgical removal of the tumour. At this stage, oncologists need to determine whether chemotherapy is essential. This is where the Canassist Breast test report becomes crucial, as it evaluates the risk of cancer recurrence based on tumour biology. By analysing key biomarkers, the Canassist breast test results support personalised treatment strategies. If the patient is deemed low-risk, they may be spared the physical and emotional burden of chemotherapy. Conversely, those categorised as high-risk can be given a more aggressive treatment plan to improve long-term outcomes. The Canassist breast test procedure provides clinicians with the data necessary to make confident, evidence-based decisions.

Time Required for Test Report + Next Step

At MAX Lab, the Canassist breast test procedure is streamlined to offer patients a seamless and efficient diagnostic experience.

Test Procedure

Sample Collection: The Canassist Breast test requires a formalin-fixed paraffin-embedded (FFPE) tumour tissue sample, usually obtained after a biopsy or surgery.
Lab Analysis: Forward the sample to a specialised laboratory where the expression of five crucial protein biomarkers is analysed using immunohistochemistry (IHC). The Canassist Breast lab test uses a proprietary algorithm to assign a risk category.
Test Duration: The Canassist Breast test report is generally available within 10 to 14 working days once the tissue sample is received at the lab.

Understanding the Test Report

The Canassist Breast test results provide a risk score and indicate whether the patient falls into the low- or high-risk category:

Low-risk: Likely to benefit from hormone therapy alone
High-risk: May require chemotherapy in addition to hormone therapy

The detailed Canassist breast test report includes:

Risk score
Biomarker details
Clinical interpretation
Treatment recommendations for oncologists

Next Steps After the Report

Once the Canassist breast test report is ready, MAX Lab coordinates a consultation with the oncology team. During this consultation, the oncologist:

Explains the risk score and its implications
Recommends treatment based on risk category
Discusses side effects, next steps, and long-term management

Includes 1 other tests

₹ 500

See Details ADD

HbA1c, Glycated Hemoglobin Test

₹ 600

See Details ADD

₹ 4500

See Details ADD

Typhidot Test

₹ 490

See Details ADD

Dengue IgG Test

Includes 1 other tests

₹ 600

See Details ADD

The CanAssist test for breast cancer is a revolutionary diagnostic tool that assesses an individual's risk of developing breast cancer in their lifetime. This innovative test analyzes specific genetic markers associated with the disease, providing valuable insights into an individual's predisposition to breast cancer.

The risk score for CanAssist Breast is a crucial component of this innovative test. It helps determine an individual's likelihood of developing breast cancer in their lifetime. This score is calculated based on various factors, including genetic markers and personal health history.

The CanAssist test for breast cancer recurrence is a groundbreaking diagnostic tool that helps in predicting the risk of cancer coming back after initial treatment. It analyzes specific genetic markers and provides an individualized risk score to guide further treatment decisions.

Ideally, CanAssist should be performed before any signs or symptoms of breast cancer appear. Early detection is key in successfully treating breast cancer, so it's important to identify potential risks as early as possible.

One common test used to confirm the presence of breast cancer is a biopsy. During this procedure, a small sample of tissue is taken from the suspicious area and sent to a laboratory for analysis. The tissue sample can be obtained through various methods such as fine needle aspiration, core needle biopsy, or surgical biopsy.

Queries about this test

#1 Canassist - Breast Test meaning

Ans: Canassist - Breast Test, also known as CanBREAST, is a revolutionary screening tool designed to detect breast cancer at an early stage. It utilizes advanced technology and artificial intelligence algorithms to analyze images of the breasts and identify potential abnormalities.

#2 Risk in Canassist - Breast Test

Ans: First and foremost, it's important to understand that any medical procedure carries some level of risk. The Canassist - Breast Test involves taking a small tissue sample from the breast, which can result in bleeding or infection at the site of biopsy. However, these risks are generally minimal and can typically be managed effectively by healthcare professionals.

#3 Canassist - Breast Test procedure

Ans: During the procedure, the patient will be asked to remove their clothing from the waist up and put on a gown. The technician will then position the patient in front of the Canassist machine and instruct them on how to place their breasts onto two plates attached to the device.

#4 Use of Canassist - Breast Test

Ans: The use of Canassist - Breast Test is crucial in detecting breast cancer at an early stage. This test helps in identifying the presence of specific genetic mutations that are associated with a higher risk of developing breast cancer.

#5 Canassist - Breast Test meaning in hindi

Ans: कैनासिस्ट - ब्रेस्ट टेस्ट, जिसे कैनब्रेस्ट के नाम से भी जाना जाता है, एक क्रांतिकारी स्क्रीनिंग टूल है जिसे शुरुआती चरण में स्तन कैंसर का पता लगाने के लिए डिज़ाइन किया गया है। यह स्तनों की छवियों का विश्लेषण करने और संभावित असामान्यताओं की पहचान करने के लिए उन्नत तकनीक और कृत्रिम बुद्धिमत्ता एल्गोरिदम का उपयोग करता है।

Customer reviews

5 out of 5

5 star

100%

4 star

3 star

Review this test

Share your thoughts with others

Trusted Service & Professional Staff

Max Lab has become my go-to for health tests. The staff is professional, the process is smooth, and I always feel confident about the accuracy of their reports. Highly trustworthy!